Live feed
Filing
SC 13G
SC 13G0001535610-18-000081·AIM ImmunoTech Inc.
Schedule 13G ownership disclosure
HEMISPHERX BIOPHARMA INC
Security class unavailable · CUSIP: 42366C301
Event date: 2018-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 500,000
- Percent of class
- 1.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000081
- Form type
- SC 13G
- Filer
- AIM ImmunoTech Inc.
- CIK
- CIK 946644
- Filed
- Apr 24, 2018
- Reporting period
- Apr 20, 2018
- Description
- Schedule 13G beneficial ownership